Clin2
NCT05203965Possibly a fitRecruiting

Brain imaging study testing mavoglurant in alcohol risk

Familial Alcoholism Vulnerability

Part of Brain & nervous system, Mental health clinical trials.

This early-stage study uses brain scans to understand how brain signaling tied to alcohol vulnerability works, and it tests mavoglurant, a medicine that blocks a brain receptor. Results may help researchers learn why some people are more vulnerable to alcohol problems.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
80 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are 18–45 years old
  • Your IQ is estimated to be above 70, and you can follow all study instructions
  • You do not have major brain or nervous system problems (like epilepsy) and no serious head injury recently
  • Your MRI is safe for you (no metal/implants in your body and you can handle being in the scanner)
  • You test negative for alcohol and drugs (and for pregnancy if you could become pregnant) on the scan day
  • You do not currently have psychosis or ongoing major mood/anxiety problems, and you have no alcohol or substance use disorder that is severe (and you must not have recent withdrawal/craving issues)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06136195Recruiting· Phase 1
Mavoglurant for alcohol craving in heavy drinkers

This trial tests whether a medication called mavoglurant can reduce alcohol cravings and drinking in people who are heavy drinkers with alcohol use disorder and are not looking for treatment.

New Haven, Connecticut
NCT06793488Recruiting· Early Phase 1
Anxiety and alcohol use disorder treatment study

This study tests whether a medication called disulfiram (Antabuse) can help people with alcohol use disorder (AUD) feel less anxious when they stop drinking. Researchers will also use brain scans (MRI) to look at how the brain changes during early abstinence.

New York, New York
NCT05957159Recruiting· Early Phase 1
Testing an alcohol brain imaging study based on opioid receptor balance

This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.

New Haven, Connecticut
NCT05929677Recruiting· Early Phase 1
Study tests effects on impulsivity and how alcohol feels

This early-phase study looks at how alcohol affects impulsivity (tendency to act quickly) and people’s subjective experiences. You may be able to join if you drink regularly and meet the study safety rules.

Boston, Massachusetts
NCT06371404Recruiting
Brain imaging study of stress and alcohol use disorders

This study uses a special brain scan to look at how stress and alcohol use affect the brain. It may help people with PTSD, alcohol use disorder, or healthy volunteers understand these conditions better.

New Haven, Connecticut
NCT06795581Recruiting· Phase 1
Brain imaging study for alcohol use disorder

This study uses a special brain scan (PET) to look at a protein called PDE4B in people with alcohol use disorder. The goal is to better understand how alcohol affects the brain, which may lead to new treatments.

Bethesda, Maryland

Hear when a new Familial Alcoholism Vulnerability trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.